News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
141 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
2 (104)
3 (173)
4 (173)
5 (128)
6 (1)
7 (23)
8 (258)
9 (151)
10 (98)
11 (90)
12 (52)
13 (1)
14 (1)
15 (70)
16 (158)
17 (130)
18 (132)
19 (69)
20 (4)
21 (3)
22 (130)
23 (153)
24 (124)
25 (141)
26 (79)
27 (1)
28 (1)
29 (133)
30 (155)
31 (147)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Vascular Insights Announces New CEO
The company’s Board of Directors has appointed James P. Ott as President and CEO.
January 25, 2018
·
1 min read
Pharm Country
PAVmed Announces Closing of Over-Allotment Option with Respect to Firm Commitment Common Stock Offering
The Firm Shares and the Option Shares were sold at a public offering price of $1.80 per share.
January 25, 2018
·
4 min read
Business
Endologix, Inc. to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on February 21, 2018
The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
January 25, 2018
·
1 min read
Genetown
PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year 2017
The Company reported GAAP losses per share from continuing operations of $0.35, including the impact of the Tax Cuts and Jobs Act of 2017, as compared to GAAP earnings per share from continuing operations of $0.57 in the fourth quarter of 2016.
January 25, 2018
·
35 min read
Biotech Bay
Bay Area’s ARMO BioSciences Raises $128M in IPO
The offering is expected to close on January 30, 2018, subject to customary closing conditions.
January 25, 2018
·
3 min read
Business
ESSA Announces Management Team Change
ESSA Pharma announced today that Frank Perabo, M.D., Ph.D., will depart ESSA as the Company’s Chief Medical Officer to pursue other opportunities, effective January 31, 2018.
January 25, 2018
·
5 min read
Policy
Alnylam Announces EMA Acceptance of MAA for Patisiran for the Treatment of Hereditary ATTR (hATTR) Amyloidosis
The filing of the MAA was previously announced on December 18, 2017.
January 25, 2018
·
8 min read
Pharm Country
Senseonics Announces Proposed Convertible Senior Subordinated Notes Offering
Senseonics today announced a proposed underwritten offering, subject to market and other conditions, of convertible senior subordinated notes due 2023 (the Notes).
January 25, 2018
·
4 min read
Breathtec Biomedical Provides Development Update on Breathalyzer for Disease Detection
In collaboration with Cannabix Technologies (CSE:BLO), the V2 prototype is now complete.
January 25, 2018
·
4 min read
Business
Advanced Bifurcation Systems Appoints Industry Veteran Thomas O’Neill to Board of Directors
Mr. O’Neill is an industry veteran who brings more than 30 years of Board and executive-level experience in the financial markets and medical devices to ABS.
January 25, 2018
·
3 min read
Previous
13 of 15
Next